Showing results (131-140 of 168) with videos related to
Sort By:
Pageof 17
Advances in Experimental Medicine and Biology|October 15, 2016
Progress Towards Computational 3-D Multicellular Systems BiologyPaul Macklin, Hermann B Frieboes, Jessica L Sparks, et al.Cancer Informatics|August 6, 2015
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer CellsShannon M Mumenthaler, Jasmine Foo, Nathan C Choi, et al.Archives of Neurology|July 25, 1998
Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurementsW Block, J Karitzky, F Träber, et al.Scientific Reports|July 26, 2016
A high-content image-based method for quantitatively studying context-dependent cell population dynamicsColleen M Garvey, Erin Spiller, Danika Lindsay, et al.Neurology|August 26, 1998
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study GroupG D Borasio, W Robberecht, P N Leigh, et al.Molecular Cancer Therapeutics|October 15, 2009
Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanesShannon M Mumenthaler, Patricia Y B Ng, Amanda Hodge, et al.Molecular Oncology|July 27, 2021
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancerNikhil Baban Ghate, Sangnam Kim, Erin Spiller, et al.SLAS Discovery : Advancing Life Sciences R & D|May 1, 2020
Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug ResponseSeungil Kim, Sarah Choung, Ren X Sun, et al.Oncogene|April 13, 2021
Clocking cancer: the circadian clock as a target in cancer therapyFrancesca Battaglin, Priscilla Chan, Yuanzhong Pan, et al.Cancers|June 3, 2020
Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer ChemoresistanceColleen M Garvey, Roy Lau, Alyssa Sanchez, et al.Pageof 17